Chen, D. C., Potok, O. A., Rifkin, D., & Estrella, M. M. (2022). Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. Kidney360, 3(10), 1807-1814. https://doi.org/10.34067/KID.0003202022
Citace podle Chicago (17th ed.)Chen, Debbie C., O. Alison Potok, Dena Rifkin, a Michelle M. Estrella. "Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR." Kidney360 3, no. 10 (2022): 1807-1814. https://doi.org/10.34067/KID.0003202022.
Citace podle MLA (9th ed.)Chen, Debbie C., et al. "Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR." Kidney360, vol. 3, no. 10, 2022, pp. 1807-1814, https://doi.org/10.34067/KID.0003202022.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..